Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Klaria Pharma Holding Logo
Klaria Pharma Holding Growth Score
93
CB Rank
61955
Heat Score
85
Klaria's business concept is to develop and commercialize innovative products
Founded
obfuscation
PublicPost-IPO Debt Uppsala, Uppsala Lan, Sweden1-10 www.klaria.com/en
Pharmaceutical
Overview

Klaria Pharma Holding
Total Funding
obfuscation
Growth Score
93
Heat Score
85

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score93
0 pts
in past quarter
Heat Score 85
25 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Klaria Pharma Holding

CB Rank
61955
Klaria's business concept is to develop and commercialize innovative products
Founded
obfuscation
PublicPost-IPO Debt Uppsala, Uppsala Lan, Sweden1-10 www.klaria.com/en
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Klaria AB
Operating Status Active
Stock Symbol  STO:KLAR
Company Type For Profit
Founders  Fredrik Hübinette, Scott Boyer
About the Company
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative, rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses.
Phone Number +46 (0) 8 446 42 99
Contact Email info@klaria.com
Predictions & Insights

Growth Insight

See this Growth Insight
Klaria Pharma Holding is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Growth Prediction

See this Growth Prediction

Products & Services

Sumatriptan Alginate Film
A pharmaceutical product for treating migraine via fast administration through the oral mucosa using patented alginate film technology.
Epinephrine Alginate Film
A research and development project for an alginate film delivering epinephrine to treat anaphylactic shock.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Klaria Pharma Holding Logo
Post-IPO Debt - Klaria Pharma Holding
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
EISMEA Logo
EISMEA
—
Grant - Klaria Pharma Holding Logo
Grant - Klaria Pharma Holding
—
EISMEA Logo
EISMEA
—
Grant - Klaria Pharma Holding Logo
Grant - Klaria Pharma Holding
—
EISMEA Logo
EISMEA
—
Grant - Klaria Pharma Holding Logo
Grant - Klaria Pharma Holding
—
EISMEA Logo
EISMEA
—
Grant - Klaria Pharma Holding Logo
Grant - Klaria Pharma Holding
—
EISMEA Logo
EISMEA
—
Grant - Klaria Pharma Holding Logo
Grant - Klaria Pharma Holding
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Contacts 1

Employee Profiles

News

News and Press

News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

138
187.5%
 in past month

IT Spend

$110.1KThis year, Klaria Pharma Holding is projected to spend $110.1K on IT, according to Aberdeen.

Active Website Tech Count

4Klaria Pharma Holding is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m, Cloudflare Insights, and  Cloudflare Web Analytics.

Total IP

13The intellectual property of Klaria Pharma Holding includes 13 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Klaria Pharma Holding's headquarters? Klaria Pharma Holding is located in Uppsala, Uppsala Lan, Sweden.Who invested in Klaria Pharma Holding? Klaria Pharma Holding is funded by EISMEA.When was the last funding round for Klaria Pharma Holding? Klaria Pharma Holding closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Klaria Pharma Holding's competitors? Alternatives and possible competitors to Klaria Pharma Holding may include Aquestive Therapeutics and  Amerge.How much funding has Klaria Pharma Holding raised to date? Klaria Pharma Holding has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ab5958e 1)
|